期刊文献+

乙型肝炎病毒前S1抗原与HBVDNA定量检测相关性分析及临床应用价值 被引量:4

HBV Pre-S1antigen and its correlation with HBV DNA quantitative PCR detection and clinical applications as HBV replication markers
原文传递
导出
摘要 目的探讨乙型肝炎(乙肝)患者前S1(Pre S1)抗原检测和乙型肝炎病毒(HBV)DNA检测以及乙肝病毒血清标志物("乙肝五项")之间的关系,同时研究Pre S1抗原和HBV DNA在乙型肝炎诊断中的重要性。方法对537例乙肝患者血清用酶联免疫吸附试验(ELISA)法测定Pre S1抗原和HBV血清学标志物,用实时荧光定量聚合酶链反应(FQ-PCR)法进行HBV DNA检测,并对检测数据采用χ2检验进行比较分析。结果 537例乙肝患者血清中,HBV DNA总阳性率为52.70%;前S1抗原总阳性率为49.35%,两者间比较差异无统计学意义(χ2=1.21,P>0.05),而且Pre S1抗原和HBV DNA检测的符合率为93.62%。在HBV DNA阳性乙肝患者中Pre S1抗原检测阳性率为89.05%,HBeAg检测阳性率为37.46%,两者间差异有统计学意义(χ2=30.79,P<0.01)。结论 Pre S1抗原与HBV DNA具有高度相关性,并且能够比HBeAg更敏感地反映乙肝病毒的复制情况,Pre S1抗原可作为血清标志物检测的重要补充,更适合在无条件进行HBV DNA检测的基层医院开展。 Objective To study the correlation between pre S1 (Pre-S1) antigen detection and hepatitis B virus (HBV) DNA quantitative PCR (qPCR) as HBV replication markers. Methods A total of 537 hepatitis B pa- tients were recruited in the study. HBV Pre-S1 antigen and other HBV markers were detected by enzyme linked immunosorbent assay (ELISA) . HBV DNA was assayed by qPCR. Results Among 537 hepatitis B patients, the positive rates of HBV DNA and Pre-S1 were 52.70% and 49. 340/00, respectively (X2 =1.21, P 〉0.05) and the overlapping rates of these two methods was 93.62%. Pre-S1 antigen was positive in 89.05 of cases with HBV DNA positive while HBeAg positive was only 37.46% (X2 =30.79, P〈0.01). Conclu- sions Pre-S1 antigen and HBV DNA are highly correlated to reflect the HBV replication status. Pre-Sl anti- gen detection can be a sensitive serum marker to reflect HBV replication.
出处 《中国病毒病杂志》 CAS 2013年第6期455-458,共4页 Chinese Journal of Viral Diseases
关键词 乙型肝炎病毒 前S1抗原 HBV DNA 血清标志物 Hepatitis B virus Pre-S1 antigem HBV DNA; HBV markers
  • 相关文献

参考文献1

二级参考文献30

  • 1van Zonneveld M,Honkoop P,Hansen BE,Niesters HG,Murad SD,de Man RA, Schalm SW,Janssen HL.Long-term follow-up of alpha-interferon treatment of patients with chronic hapatitis B.Hepatology 2004,39: 804-810.
  • 2Ganem D,Prince AM.Hepatitis B virus infection-natural history and clinical consequences.N Engl J Med 2004;350:1118-1129.
  • 3Hoofnagle JH,Dusheiko GM,Seeff LB,Jones EA,Waggoner JG,Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.Ann Intern Med 1981;94:744-748.
  • 4Liaw YF,Chu CM,Su IJ,Huang MJ,Lin DY,Chang-Chien CS.Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology 1983;84:216-219.
  • 5Lin CL,Liao LY,Liu CJ,Chen PJ,Lai MY,Kao JH,Chen DS.Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B.J Gastroenterol 2002;37:283-287.
  • 6Schiefke I,Klecker C,Maier M,Oesen U,Etzrodt G,Tannapfel A,Liebert UG,Berr F.Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.Liver Int 2004;24:98-104.
  • 7Bonino F,Rosina F,Rizzetto M,Rizzi R,Chiaberge E,Tardanico R,Callea F,Verme G.Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.Gastroenterology 1986:90(5 Pt 1):1268-1273.
  • 8Chu CM,Karayiannis P,Fowler MJ,Monjardino J,Liaw YF,Thomas HC. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.Henatnlogy 1985.5:431-434.
  • 9Yotsuyanagi H,Hino K,Tomita E,Toyoda J,Yasuda K,Iino S.Precore and core promoter mutations,hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B.J Hepatol 2002;37:355-363.
  • 10Yuen MF,Sablon E,Yuan HJ,Hui CK,Wong DK,Doutreloigne J,Wong BC,Chan AO,Lai CL.Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus,J Infect Dis 2002; 186:1335-1338.

共引文献34

同被引文献44

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部